Tag Archives: Pembrolizumab

Report says hardly any physicians read the medical journals for their particular field. Has era of “evidence-free medicine” finally arrived?

The News: It was not long ago when it was possible for physicians to keep up with the medical literature. A conscientious physician who subscribed to the 3-4 leading journals… Read more »

Merck’s Keytruda aces another cancer trial as results dazzle researchers

The News: Hot on the heels of the final presentation at ASCO’s 4-day conference in Chicago, a small, new study is causing jaws to drop after it found that a… Read more »

Merck’s Keytruda gets chemo-combo approval for lung cancer; science, stars align for multi-billion medicine

The News: Merck & Co. announced Wednesday (May 10, 2017) that the FDA awarded accelerated approval to Keytruda (pembrolizumab), in combination with Eli Lilly & Co.’s chemotherapy regimen Alimta (pemetrexed)… Read more »